Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 35.08%39.15M | 116.79%35.95M | -11.15%137.51M | 117.37%47.53M | -34.41%44.26M | -28.58%28.98M | -33.24%16.58M | -2.72%154.76M | -62.08%21.86M | 49.87%67.48M |
| Cost of revenue | 13.78%26.95M | 107.53%26.15M | -15.48%91.89M | 382.69%30.34M | -50.24%24.64M | -28.30%23.68M | -36.67%12.6M | -19.13%108.73M | -87.16%6.29M | 26.05%49.52M |
| Gross profit | 130.26%12.2M | 146.08%9.8M | -0.90%45.62M | 10.33%17.19M | 9.23%19.62M | -29.80%5.3M | -19.46%3.98M | 86.87%46.04M | 78.84%15.58M | 212.92%17.97M |
| Operating expense | 42.34%5.83M | 64.37%3.84M | 8.03%19.82M | 12.24%8.62M | 33.17%8.48M | -0.27%4.1M | -44.34%2.34M | 21.17%18.35M | 110.15%7.68M | 30.59%6.37M |
| Selling and administrative expenses | 46.64%6.13M | 9.53%3.95M | 4.10%18.39M | 27.73%6.13M | -2.70%4.51M | 2.93%4.18M | -13.58%3.61M | 21.97%17.67M | 58.68%4.8M | -4.59%4.63M |
| -General and administrative expense | 46.64%6.13M | 9.53%3.95M | 4.10%18.39M | 27.73%6.13M | -2.70%4.51M | 2.93%4.18M | -13.58%3.61M | 21.97%17.67M | 58.68%4.8M | -4.59%4.63M |
| Other operating expenses | ---- | ---- | 43.31%1.43M | -13.59%2.49M | 128.84%3.98M | 113.73%109K | 2,221.05%441K | -7.84%998.8K | 172.85%2.88M | 7,795.45%1.74M |
| Total other operating income | 269.62%292K | -90.97%115K | --0 | ---- | ---- | --79K | --1.27M | -25.55%317.35K | ---- | ---- |
| Operating profit | 430.03%6.37M | 261.93%5.96M | -6.83%25.8M | 8.47%8.57M | -3.92%11.14M | -65.07%1.2M | 119.89%1.65M | 191.70%27.69M | 56.21%7.9M | 1,243.57%11.6M |
| Net non-operating interest income (expenses) | 58.44%-165K | -53.90%-237K | 469.11%1.12M | 0.74%-134K | 24.03%-98K | -47.58%-397K | 47.44%-154K | 121.12%197.63K | -202.01%-135K | -180.43%-129K |
| Non-operating interest income | ---- | ---- | 84.07%1.88M | ---- | ---- | ---- | ---- | 164.22%1.02M | ---- | ---- |
| Non-operating interest expense | -58.44%165K | 53.90%237K | -8.09%758.92K | -0.74%134K | -24.03%98K | 47.58%397K | -47.44%154K | -37.59%825.72K | -47.05%135K | 180.43%129K |
| Net investment income | 83.48%564.18K | -40.19%307.49K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 58.85%-818.9K | 64.91%188K | 35.97%1.72M | -49.66%-1.99M | ||||||
| Less:Other special charges | ---- | ---- | -263.41%-1.15M | ---- | ---- | ---- | ---- | -212.16%-317.09K | ---- | ---- |
| Less:Write off | ---- | ---- | -14.56%1.97M | ---- | ---- | -64.91%-188K | -35.97%-1.72M | 61.20%2.31M | ---- | ---- |
| Other non-operating income (expenses) | -55.19%1.16M | -53.36%118K | 33.90%175.93K | 150.48%2.1M | -18.55%461K | 790.34%2.58M | -37.22%253K | -82.76%131.39K | 270.44%838K | 433.96%566K |
| Income before tax | 117.39%7.36M | 234.59%5.84M | 1.94%26.84M | 22.44%10.54M | -4.40%11.5M | -5.29%3.39M | -17.68%1.75M | 209.70%26.33M | 144.23%8.6M | 645.94%12.03M |
| Income tax | 108.57%1.97M | 176.51%1.51M | 21.89%8.07M | 41.34%3.03M | 45.93%3.62M | -17.90%945K | -35.58%545K | 291.88%6.62M | 194.61%2.14M | 7,394.12%2.48M |
| Net income | 120.80%5.39M | 260.95%4.34M | -4.77%18.77M | 16.17%7.51M | -17.46%7.88M | 0.70%2.44M | -5.80%1.2M | 189.33%19.71M | 131.12%6.46M | 479.96%9.55M |
| Net income continuous operations | 120.80%5.39M | 260.95%4.34M | -4.77%18.77M | 16.17%7.51M | -17.46%7.88M | 0.70%2.44M | -5.80%1.2M | 189.33%19.71M | 131.12%6.46M | 479.96%9.55M |
| Noncontrolling interests | 218K | 135K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 111.88%5.17M | 249.71%4.2M | -4.77%18.77M | 16.17%7.51M | -17.46%7.88M | 0.70%2.44M | -5.80%1.2M | 189.33%19.71M | 131.12%6.46M | 479.96%9.55M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 111.88%5.17M | 249.71%4.2M | -4.77%18.77M | 16.17%7.51M | -17.46%7.88M | 0.70%2.44M | -5.80%1.2M | 189.33%19.71M | 131.12%6.46M | 479.96%9.55M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 111.90%0.0089 | 242.86%0.0072 | -5.00%0.0323 | 16.22%0.0129 | -17.58%0.0136 | 0.00%0.0042 | -4.55%0.0021 | 190.60%0.034 | 131.25%0.0111 | 489.29%0.0165 |
| Diluted earnings per share | 111.90%0.0089 | 242.86%0.0072 | -5.00%0.0323 | 16.22%0.0129 | -17.58%0.0136 | 0.00%0.0042 | -4.55%0.0021 | 190.60%0.034 | 131.25%0.0111 | 489.29%0.0165 |
| Dividend per share | 0 | 0.01 | -50.00%0.01 | 0 | 0 | 66.67%0.01 | 0 | 0.02 | 0.014 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.